| Code | Description | Claims | Beneficiaries | Total Paid |
| 0450 |
Emergency room services |
25,797 |
22,956 |
$1.56M |
| 90999 |
Unlisted dialysis procedure, inpatient or outpatient |
5,455 |
451 |
$871K |
| 0682 |
|
128 |
128 |
$512K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,461 |
2,406 |
$452K |
| J0882 |
Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) |
999 |
272 |
$414K |
| 0510 |
|
12,267 |
10,788 |
$403K |
| J0606 |
Injection, etelcalcetide, 0.1 mg |
971 |
79 |
$367K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,691 |
1,385 |
$343K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,844 |
2,436 |
$324K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,766 |
3,499 |
$250K |
| 80053 |
Comprehensive metabolic panel |
19,045 |
17,565 |
$226K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,821 |
7,250 |
$205K |
| 0762 |
|
372 |
254 |
$205K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,565 |
2,246 |
$203K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,194 |
1,021 |
$198K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,404 |
3,250 |
$194K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
21,084 |
19,200 |
$186K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
2,098 |
1,987 |
$160K |
| 0760 |
|
12,561 |
11,287 |
$137K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,751 |
1,681 |
$131K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,569 |
2,327 |
$115K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,815 |
2,526 |
$115K |
| 71045 |
Radiologic examination, chest; single view |
11,045 |
9,222 |
$100K |
| 0270 |
|
15,923 |
6,763 |
$99K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,397 |
3,110 |
$96K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,038 |
1,979 |
$94K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,115 |
1,001 |
$88K |
| 0250 |
|
13,884 |
4,807 |
$86K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
803 |
802 |
$86K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,087 |
1,063 |
$77K |
| J3490 |
Unclassified drugs |
6,787 |
3,477 |
$75K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,423 |
2,370 |
$75K |
| 71046 |
Radiologic examination, chest; 2 views |
3,435 |
3,106 |
$72K |
| 83880 |
|
1,997 |
1,883 |
$69K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
335 |
335 |
$69K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,482 |
4,422 |
$69K |
| 0360 |
|
1,027 |
970 |
$66K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,094 |
975 |
$66K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,286 |
2,231 |
$65K |
| 84484 |
|
5,069 |
4,666 |
$64K |
| G0378 |
Hospital observation service, per hour |
353 |
324 |
$64K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
406 |
382 |
$61K |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,931 |
255 |
$46K |
| 99199 |
Unlisted special service, procedure or report |
824 |
715 |
$42K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
272 |
226 |
$41K |
| 0750 |
|
309 |
306 |
$41K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,038 |
2,031 |
$39K |
| 81001 |
|
9,131 |
8,641 |
$37K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,434 |
517 |
$36K |
| 71250 |
|
240 |
235 |
$34K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
552 |
532 |
$33K |
| 86141 |
|
2,496 |
2,430 |
$31K |
| 83690 |
|
3,429 |
3,240 |
$30K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,126 |
446 |
$30K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,803 |
1,778 |
$29K |
| 73130 |
|
1,132 |
1,025 |
$29K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
487 |
445 |
$29K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,194 |
3,038 |
$28K |
| 87088 |
|
3,545 |
3,380 |
$28K |
| 70486 |
|
206 |
191 |
$28K |
| 70498 |
|
169 |
138 |
$28K |
| 80061 |
Lipid panel |
3,333 |
3,315 |
$27K |
| 72170 |
|
1,266 |
1,051 |
$27K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
325 |
313 |
$27K |
| 83735 |
|
3,126 |
2,787 |
$27K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
567 |
503 |
$26K |
| J1756 |
Injection, iron sucrose, 1 mg |
245 |
65 |
$26K |
| 83605 |
|
1,551 |
1,453 |
$24K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
460 |
395 |
$24K |
| 73610 |
|
963 |
867 |
$24K |
| 85610 |
|
5,284 |
4,986 |
$24K |
| 86780 |
|
1,365 |
1,322 |
$23K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,655 |
3,626 |
$23K |
| 93970 |
|
131 |
127 |
$23K |
| 86803 |
|
1,831 |
1,822 |
$21K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
788 |
787 |
$21K |
| 92557 |
|
231 |
231 |
$21K |
| 0761 |
|
1,773 |
1,577 |
$20K |
| 93971 |
|
184 |
173 |
$19K |
| 76801 |
|
296 |
244 |
$19K |
| 73630 |
|
783 |
720 |
$18K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
68 |
68 |
$18K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
106 |
105 |
$18K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,694 |
1,577 |
$18K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,526 |
1,502 |
$18K |
| 90715 |
|
351 |
351 |
$18K |
| 84702 |
|
1,221 |
1,113 |
$18K |
| 92588 |
|
357 |
357 |
$17K |
| 73110 |
|
713 |
641 |
$17K |
| 76830 |
Ultrasound, transvaginal |
270 |
264 |
$17K |
| 0710 |
|
603 |
588 |
$17K |
| 85730 |
|
2,375 |
2,286 |
$17K |
| 86703 |
|
1,647 |
1,641 |
$16K |
| 82948 |
|
2,092 |
1,709 |
$16K |
| 87040 |
|
670 |
647 |
$16K |
| 81025 |
|
2,957 |
2,836 |
$16K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
323 |
312 |
$15K |
| 86481 |
|
256 |
253 |
$15K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
190 |
161 |
$13K |
| 80143 |
|
569 |
542 |
$13K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
167 |
167 |
$13K |
| 73560 |
|
723 |
681 |
$12K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
441 |
398 |
$12K |
| 87070 |
|
1,127 |
1,106 |
$12K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
61 |
56 |
$12K |
| 94729 |
|
266 |
264 |
$11K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,226 |
1,179 |
$11K |
| 90675 |
|
27 |
15 |
$11K |
| 73030 |
|
433 |
411 |
$11K |
| 71271 |
|
99 |
99 |
$11K |
| 94726 |
|
262 |
260 |
$10K |
| 87340 |
|
1,211 |
1,194 |
$10K |
| 74018 |
|
476 |
453 |
$10K |
| 82728 |
|
865 |
850 |
$10K |
| 84439 |
|
1,195 |
1,178 |
$10K |
| 76770 |
|
127 |
125 |
$10K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
739 |
711 |
$9K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
194 |
191 |
$9K |
| 92550 |
|
388 |
388 |
$9K |
| 59025 |
Fetal non-stress test |
360 |
313 |
$9K |
| 86850 |
|
1,627 |
1,565 |
$9K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
935 |
793 |
$9K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
105 |
103 |
$9K |
| 76641 |
|
110 |
109 |
$9K |
| 82077 |
|
433 |
419 |
$8K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
343 |
314 |
$8K |
| 84145 |
|
286 |
283 |
$8K |
| 97750 |
|
202 |
110 |
$8K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
197 |
125 |
$7K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
534 |
518 |
$7K |
| 82607 |
|
714 |
712 |
$7K |
| 86706 |
|
761 |
752 |
$7K |
| 86901 |
|
1,664 |
1,600 |
$7K |
| 94060 |
|
236 |
234 |
$7K |
| 80069 |
|
943 |
874 |
$7K |
| 86160 |
|
317 |
314 |
$7K |
| 72131 |
|
46 |
44 |
$6K |
| 83970 |
|
165 |
158 |
$6K |
| 85651 |
|
2,088 |
2,062 |
$6K |
| 87634 |
|
80 |
75 |
$6K |
| 0160 |
|
79 |
66 |
$6K |
| 73070 |
|
275 |
259 |
$6K |
| 85027 |
|
1,017 |
628 |
$6K |
| 86900 |
|
1,674 |
1,610 |
$6K |
| 86704 |
|
481 |
479 |
$6K |
| 96367 |
|
123 |
93 |
$5K |
| 73090 |
|
254 |
228 |
$5K |
| 73562 |
|
266 |
256 |
$5K |
| 73590 |
|
242 |
222 |
$5K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
729 |
659 |
$5K |
| 83550 |
|
760 |
750 |
$5K |
| 76536 |
|
80 |
80 |
$5K |
| 87632 |
|
30 |
25 |
$5K |
| 72100 |
|
165 |
164 |
$5K |
| 80076 |
|
589 |
587 |
$5K |
| 77066 |
Tomosynthesis, mammo |
31 |
31 |
$5K |
| 86225 |
|
375 |
371 |
$4K |
| 87186 |
|
410 |
396 |
$4K |
| 82550 |
|
502 |
468 |
$4K |
| 73552 |
|
113 |
106 |
$4K |
| J1453 |
Injection, fosaprepitant, 1 mg |
52 |
37 |
$4K |
| 87077 |
|
485 |
470 |
$4K |
| 86705 |
|
333 |
332 |
$4K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
87 |
85 |
$4K |
| 80179 |
|
195 |
188 |
$4K |
| 73502 |
|
111 |
106 |
$4K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
36 |
34 |
$4K |
| 99070 |
|
592 |
281 |
$3K |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
190 |
105 |
$3K |
| 0324 |
|
60 |
51 |
$3K |
| 93000 |
|
80 |
78 |
$3K |
| 93308 |
|
33 |
33 |
$3K |
| 73140 |
|
210 |
193 |
$3K |
| 95811 |
|
12 |
12 |
$3K |
| 99000 |
|
935 |
870 |
$3K |
| 82565 |
|
605 |
553 |
$3K |
| 76870 |
|
70 |
67 |
$3K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
76 |
43 |
$3K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
61 |
42 |
$3K |
| 84100 |
|
522 |
451 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,360 |
2,303 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
91 |
91 |
$3K |
| 85379 |
|
191 |
189 |
$3K |
| 94664 |
|
231 |
231 |
$2K |
| 93793 |
|
886 |
658 |
$2K |
| 74022 |
|
67 |
64 |
$2K |
| 82803 |
|
85 |
79 |
$2K |
| 69210 |
|
72 |
71 |
$2K |
| 72040 |
|
75 |
75 |
$2K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
115 |
101 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
389 |
333 |
$2K |
| 20610 |
|
88 |
82 |
$2K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
27 |
27 |
$2K |
| 82746 |
|
146 |
144 |
$2K |
| T1999 |
Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" |
148 |
78 |
$2K |
| 84520 |
|
472 |
370 |
$2K |
| 77080 |
|
54 |
54 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
250 |
210 |
$2K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
65 |
64 |
$2K |
| 90686 |
|
54 |
51 |
$2K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
50 |
50 |
$1K |
| 71020 |
|
46 |
21 |
$1K |
| J2704 |
Injection, propofol, 10 mg |
279 |
278 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
40 |
40 |
$1K |
| 94618 |
|
109 |
108 |
$1K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
30 |
30 |
$1K |
| 82043 |
|
359 |
359 |
$1K |
| 73060 |
|
65 |
60 |
$1K |
| 86038 |
|
125 |
125 |
$1K |
| J1953 |
Injection, levetiracetam, 10 mg |
34 |
31 |
$1K |
| 0636 |
|
150 |
144 |
$1K |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
74 |
62 |
$1K |
| 81002 |
|
491 |
440 |
$1K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
141 |
139 |
$1K |
| 83721 |
|
173 |
171 |
$975.46 |
| 99499 |
|
30 |
13 |
$942.40 |
| J1815 |
Injection, insulin, per 5 units |
124 |
82 |
$940.41 |
| 36000 |
|
58 |
56 |
$923.58 |
| 93017 |
|
15 |
14 |
$908.78 |
| 86235 |
|
65 |
46 |
$836.96 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
99 |
94 |
$834.52 |
| 73020 |
|
29 |
29 |
$799.59 |
| 87210 |
|
143 |
139 |
$729.36 |
| 72110 |
|
16 |
16 |
$701.70 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13 |
13 |
$695.13 |
| 82805 |
|
13 |
12 |
$689.80 |
| A4649 |
Surgical supply; miscellaneous |
91 |
53 |
$678.70 |
| 93242 |
|
42 |
42 |
$653.04 |
| 82553 |
|
52 |
29 |
$625.92 |
| 76881 |
|
15 |
14 |
$611.16 |
| Q3014 |
Telehealth originating site facility fee |
42 |
41 |
$607.36 |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
29 |
18 |
$590.97 |
| 86430 |
|
91 |
90 |
$575.51 |
| 73521 |
|
18 |
18 |
$556.53 |
| 84550 |
|
116 |
112 |
$541.17 |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
26 |
26 |
$519.44 |
| 86255 |
|
40 |
39 |
$509.27 |
| 82009 |
|
92 |
85 |
$488.34 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
118 |
111 |
$449.06 |
| 81015 |
|
127 |
118 |
$418.19 |
| 93246 |
|
25 |
25 |
$370.50 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
16 |
15 |
$353.26 |
| 90656 |
|
14 |
14 |
$331.65 |
| 92587 |
|
13 |
13 |
$328.00 |
| 87147 |
|
68 |
68 |
$321.29 |
| 29700 |
|
16 |
16 |
$281.51 |
| 82150 |
|
45 |
32 |
$280.91 |
| 0700 |
|
16 |
12 |
$280.24 |
| J2060 |
Injection, lorazepam, 2 mg |
27 |
24 |
$271.18 |
| 82140 |
|
15 |
14 |
$268.90 |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
14 |
14 |
$267.58 |
| 72200 |
|
12 |
12 |
$264.84 |
| J1790 |
Injection, droperidol, up to 5 mg |
14 |
13 |
$258.71 |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
13 |
13 |
$236.40 |
| 86708 |
|
14 |
13 |
$187.30 |
| 87205 |
|
42 |
40 |
$176.68 |
| 83615 |
|
26 |
25 |
$166.80 |
| 99024 |
|
79 |
74 |
$135.54 |
| 87400 |
|
21 |
21 |
$130.58 |
| 84466 |
|
20 |
20 |
$123.34 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
47 |
42 |
$114.09 |
| 84481 |
|
17 |
17 |
$109.25 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
12 |
12 |
$89.15 |
| 82570 |
|
27 |
25 |
$88.93 |
| 86200 |
|
12 |
12 |
$87.18 |
| 36415 |
Collection of venous blood by venipuncture |
371 |
349 |
$82.25 |
| 94760 |
|
12 |
12 |
$68.90 |
| 83540 |
|
20 |
20 |
$64.12 |
| 84156 |
|
27 |
25 |
$62.28 |
| 86592 |
|
27 |
26 |
$61.42 |
| 0272 |
|
159 |
157 |
$29.77 |
| 87081 |
|
14 |
14 |
$27.33 |
| 80320 |
|
65 |
58 |
$11.29 |
| 80050 |
General health panel |
19 |
19 |
$0.00 |
| 80377 |
|
18 |
17 |
$0.00 |